Concepedia

Yimamu Maimaitili

YM

Statistics

Publications

2

Citations

35

H-Index

2

Active since

2018

Affiliations

Kobe University(Current)

Yimamu Maimaitili is an author at Kobe University specializing in mtor inhibitor therapy, oncology, and molecular oncology.

Publications per year

2018–2019

2

Publications

2

An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells

Yu Mizutani, Aki Inase, Yimamu Maimaitili et al. · International Journal of Hematology · 2019 · 20 citations

, , +16

An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function

Yimamu Maimaitili, Aki Inase, Yoshiharu Miyata et al. · Leukemia Research · 2018 · 15 citations · Full text

, , +14

1–2 of 2